Baxter International Inc. said in a quarterly financial report Thursday that the plant will be located in the Covington area, southeast of Atlanta.
The Deerfield, Ill.-based company said construction of the Georgia plant will begin later this year.
Deal said the Georgia operation will include warehouse and distribution facilities. He said it will involve the manufacturing of plasma-based therapies that treat chronic and life-threatening illnesses.
Deal said the company’s plans in Georgia represent an investment of more than $1 billion.
Deal said the company’s decision marks “a new era in the growth of our biosciences industry” and will have far-reaching impacts on Georgia’s economy. "
Click here to read the whole article
By ERRIN HAINES ATLANTA — Phamaceuticals and biotechnology company Baxter International Inc. announced plans Thursday to build a manufacturing plant and related facilities in Georgia, representing a $1 billion investment expected to create more than ...Read more
By Chris Reidy, Globe Staff Executives in the medical device manufacturing industry predict that a new excise tax and the burden of its related compliance costs will hurt their companies' bottom lines, according to a survey conducted by KPMG LLP, ...Read more
"Mr. Sasa's career spans 30 years in the Company's core Medical Business, and in recent years he has been deeply involved in the management of this core business," Olympus said in a statement. Olympus is the world's largest maker of endoscopes, ...Read more
By Mark Glover Phil Coelho, president and CEO of SynGen Inc. in midtown Sacramento, is back in the regenerative medicine industry in earnest. On Wednesday, he announced that his company has received $5 million from San Francisco venture capital firm ...Read more